Yen Lin Chia
- Rheumatology top 5%
- Oncology
- Immunology
- Radiology, Nuclear Medicine and Imaging top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Sylvia K. PlevritisJarrett RosenbergRaj TummalaRichard FurieCatharina LindholmFrédéric HoussiauEduardo MyslerDavid Jayne
- Topics
- Monoclonal and Polyclonal Antibodies Research (11 papers)Systemic Lupus Erythematosus Research (9 papers)Chronic Lymphocytic Leukemia Research (8 papers)
- Cited by
- RheumatologyOncologyNephrology
- Partner nations
- United StatesUnited KingdomSweden
In The Last Decade
Yen Lin Chia
32 papers receiving 534 citations
Hit Papers
Peers
Comparison fields: 5 of 67
- Rheumatology 209
- Oncology 190
- Immunology 125
- Radiology, Nuclear Medicine and Imaging 124
- Pulmonary and Respiratory Medicine 81
Countries citing papers authored by Yen Lin Chia
This map shows the geographic impact of Yen Lin Chia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yen Lin Chia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yen Lin Chia more than expected).
Fields of papers citing papers by Yen Lin Chia
This network shows the impact of papers produced by Yen Lin Chia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yen Lin Chia. The network helps show where Yen Lin Chia may publish in the future.
Co-authorship network of co-authors of Yen Lin Chia
This figure shows the co-authorship network connecting the top 25 collaborators of Yen Lin Chia. A scholar is included among the top collaborators of Yen Lin Chia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yen Lin Chia. Yen Lin Chia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 8 | |
| 4 | 4 | |
| 5 | 2 | |
| 6 | Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritisbreakdown → | 130 |
| 7 | 8 | |
| 8 | 9 | |
| 9 | 18 | |
| 10 | 14 | |
| 11 | 11 | |
| 12 | 19 | |
| 13 | 11 | |
| 14 | 1 | |
| 15 | 49 | |
| 16 | 67 | |
| 17 | 2 | |
| 18 | 1 | |
| 19 | 100 | |
| 20 | 15 |
About Yen Lin Chia
Yen Lin Chia is a scholar working on Genetics, Rheumatology and Radiology, Nuclear Medicine and Imaging, having authored 32 papers that have together received 542 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (11 papers), Systemic Lupus Erythematosus Research (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). The work is most often cited by research in Rheumatology (209 citations), Oncology (190 citations) and Nephrology (44 citations). Yen Lin Chia has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Sylvia K. Plevritis, Jarrett Rosenberg, Raj Tummala, Richard Furie, Catharina Lindholm, Frédéric Houssiau, Eduardo Mysler, David Jayne, Brad H. Rovin and Yanfeng Wang. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.